subcutaneous Enoxaparin for pre-eclampsia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Feb 2021: Trial registered, NCT04762992
  2. 18 Jul 2022: Trial started, NCT04762992

The trials

NCT04762992: LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)

State
Under way
Phase
Phase 3
People
12 planned
Started
18 Jul 2022
Primary completion
30 Jul 2026
Arms
Intervention group, enoxaparin
Results
None posted
  1. 21 Feb 2021: Trial registered
  2. 18 Jul 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.